Seizert Capital Partners, LLC Organogenesis Holdings Inc. Transaction History
Seizert Capital Partners, LLC
- $2.21 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
131Shares Held
70.3MCall Options Held
39.7KPut Options Held
0-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Assenagon Asset Management S.A.5.54MShares$25.1 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...